SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
[Safety of the blood supply in Mexico from 1999 to 2003].
6 references·2 citing·22 second hop
[Safety of the blood supply in Mexico from 1999 to 2003]. (2006)[Safety of the blood supply in Mexico fro…Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Detection of HIV-1 and HCV In…Transfusion medicine: looking to the future (2003)Transfusion medicine: looking…Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Current prevalence and incide…Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Feasibility and efficacy of r…The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection (1997)The incidence/window period m…Safety of the Blood Supply in the United States: Opportunities and Controversies (1997)Safety of the Blood Supply in…Donated Blood Screening for HIV, HCV and HBV by ID-NAT and the Residual Risk of Iatrogenic Transmission in a Tertiary Care Hospital Blood Bank in Puebla, Mexico (2023)Donated Blood Screening for H…[Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors]. (2011)[Safe blood in the absence of…Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases (2000)Current Risks of Transfusion-Transmitted Agents: A Review (2007)Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV Antibody (1988)Exposure of Patients to Human Immunodeficiency Virus through the Transfusion of Blood Components That Test Antibody-Negative (1989)Evaluation of Screened Blood Donations for Human Immunodeficiency Virus Type 1 Infection by Culture and DNA Amplification of Pooled Cells (1991)International application of the Incidence Rate/Window Period model (2002)Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services (2007)The Risk of Transfusion-Transmitted Viral Infections (1996)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Prevention of transfusion-transmitted infections (2019)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)Reducing the risk of infection from plasma products: specific preventative strategies (2000)International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 (2011)Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus (2008)Screening Blood Donors for HIV, HCV, and HBV at the American Red Cross: 10-Year Trends in Prevalence, Incidence, and Residual Risk, 2007 to 2016 (2020)Variation of platelet production and discard rates in 17 blood centers representing 10 European countries from 2000 to 2002 (2006)Progress in Global Blood Safety for HIV (2009)Quality indicators for discarding blood in the National Blood Center, Kuala Lumpur (2012)Karl landsteiner and his major contributions to haematology (2003)Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States (2004)Lessons from Cost-Effectiveness Research for United States Public Health Policy (2007)
this work references cited by second hop

References

  • 2002Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population642 cited
  • 2004Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing535 cited
  • 2003Transfusion medicine: looking to the future290 cited
  • 1999Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting254 cited
  • 1997Safety of the Blood Supply in the United States: Opportunities and Controversies173 cited
  • 1997The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection168 cited

Cited by

  • 2011[Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].12 cited
  • 2023Donated Blood Screening for HIV, HCV and HBV by ID-NAT and the Residual Risk of Iatrogenic Transmission in a Tertiary Care Hospital Blood Bank in Puebla, Mexico9 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work